Numerous studies have reported hyperactivation and frequent mutations in JAK–STAT signaling proteins in various human disorders, such as rheumatoid arthritis, inflammatory bowel disease, inflammatory skin conditions, myeloproliferative neoplasms, and solid tumors [14–17]. This evidence concerns the gene SOAT1 and myeloproliferative disorder.